Byrne Asset Management’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37K Sell
102
-75
-42% -$1.01K ﹤0.01% 560
2026
Q1
$2.37K Sell
177
-1,598
-90% -$21.4K ﹤0.01% 518
2025
Q4
$128K Hold
1,775
0.07% 188
2025
Q3
$77.3K Hold
1,775
0.05% 181
2025
Q2
$50.4K Hold
1,775
0.03% 230
2025
Q1
$52.4K Hold
1,775
0.04% 197
2024
Q4
$51.6K Sell
1,775
-150
-8% -$4.36K 0.04% 193
2024
Q3
$88.4K Sell
1,925
-150
-7% -$6.89K 0.06% 167
2024
Q2
$84.1K Sell
2,075
-350
-14% -$14.2K 0.06% 170
2024
Q1
$61.9K Hold
2,425
0.04% 188
2023
Q4
$22.7K Sell
2,425
-1,700
-41% -$15.9K 0.02% 270
2023
Q3
$26K Buy
+4,125
New +$26K 0.02% 249

Byrne Asset Management's RNA Position: Q2 2026 in Review

Byrne Asset Management reduced its PROSENSA HLDGS N V ORD SHS (NLD) (RNA) stake by 42% in Q2 2026, selling an estimated $1.01K and leaving 102 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Byrne Asset Management first reported a position in RNA in Q3 2023 and has held it in 12 quarters since. The position peaked at $128K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNA as of Q2 2026.

  • Byrne Asset Management held 102 shares of PROSENSA HLDGS N V ORD SHS (NLD) worth $1.37K as of Q2 2026.
  • Byrne Asset Management sold 75 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q2 2026, an estimated $1.01K.
  • PROSENSA HLDGS N V ORD SHS (NLD) made up ﹤0.01% of Byrne Asset Management's portfolio in Q2 2026, its #560 holding.
  • Byrne Asset Management first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q3 2023 and has held it in 12 quarters since.
  • Byrne Asset Management's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $128K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q2 2026.

Based on Byrne Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.